Eniola’s work in **replication-focused computational neuroscience/pharmacology** (e.g., CCT model pre-registered hypotheses, hERG cardiotoxicity topology study, and TOPOLOGIX resistance prediction) aligns well with the **Replication Studies** programme’s emphasis on rigorously testing prior claims. Their **Bayesian MCMC calibration, pre-registered studies, and direct validation of literature gaps** (e.g., ruling out topological features for resistance) demonstrate the methodological rigor required. The **addiction neuroscience and dynamical-systems focus** (CCT model) is a strong fit for replication in high-impact fields like pharmacology, while their **transparency (OSF/Zenodo preprints, pre-registered methods)** mirrors the programme’s open-science ethos. However, the programme’s geography (Dutch-focused) may limit accessibility unless international applications are accepted.